How should I manage a patient who is not receiving fludrocortisone?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 19, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Management of Patients Not Receiving Fludrocortisone

All patients with confirmed aldosterone deficiency (primary adrenal insufficiency) must receive mineralocorticoid replacement with fludrocortisone 1.

When Fludrocortisone is Mandatory

If your patient has primary adrenal insufficiency (PAI) and is not receiving fludrocortisone, you need to initiate it immediately. The Endocrine Society guidelines provide strong (Grade 1) recommendations that mineralocorticoid replacement is essential for all patients with confirmed aldosterone deficiency 1.

Initiation Protocol

  • Starting dose: 50-100 mcg daily in adults, taken once in the morning 1
  • Typical maintenance range: 50-200 mcg daily 1
  • Counsel patients: Do not restrict salt intake 1

Special Dosing Considerations

  • Children and newborns: Require higher doses due to lower mineralocorticoid sensitivity 1
  • Hot climates/excessive sweating: Temporary dose increases of 50-100% or increased salt intake 1
  • Prednisolone users: May need more fludrocortisone than hydrocortisone users (prednisolone has less mineralocorticoid activity) 1
  • Dexamethasone users: Require fludrocortisone as dexamethasone has no mineralocorticoid activity 1

When Fludrocortisone May Not Be Needed

Secondary adrenal insufficiency patients typically do NOT require fludrocortisone because aldosterone production remains intact (the renin-angiotensin-aldosterone system is independent of pituitary ACTH) 1.

Monitoring Strategy

Monitor replacement primarily through clinical assessment 1:

Clinical Parameters to Assess

  • Salt craving (suggests under-replacement)
  • Postural hypotension (measure sitting and standing BP; suggests under-replacement)
  • Peripheral edema (suggests over-replacement, though low sensitivity)
  • General well-being

Laboratory Monitoring

  • Serum electrolytes: Target normal range 1
  • Plasma renin activity: Upper reference range indicates appropriate dosing 1
  • Blood pressure: Both sitting and standing 1

Critical Pitfalls to Avoid

Drug Interactions

  • Licorice and grapefruit juice: Potentiate mineralocorticoid effects—patients must avoid these 1
  • Phenytoin: Increases fludrocortisone metabolism, requiring higher doses 1
  • Potassium-depleting diuretics: Enhanced hypokalemia risk—monitor potassium frequently 2
  • Digitalis: Increased arrhythmia risk with hypokalemia—monitor closely 2

Managing Hypertension on Fludrocortisone

If hypertension develops 1:

  1. First: Reduce fludrocortisone dose
  2. Second: Evaluate glucocorticoid dose (over-replacement with either can cause hypertension)
  3. Third: If hypertension persists after adjustment and patient is euvolemic, initiate antihypertensive therapy (ACE inhibitors or ARBs preferred) while continuing fludrocortisone 1

Acute Adrenal Crisis Management

During adrenal crisis with high-dose hydrocortisone (≥100 mg), fludrocortisone is not required acutely because high-dose hydrocortisone provides sufficient mineralocorticoid activity 3. Resume fludrocortisone 0.05-0.1 mg daily once transitioning to maintenance therapy 3.

Tolerance Issues in Elderly Patients

Important caveat: Fludrocortisone is poorly tolerated long-term in older patients with orthostatic hypotension (33% discontinuation rate at mean 5 months) 4. Common reasons for discontinuation include hypertension, cardiac failure, edema, and depression 4. Hypokalaemia develops in 24% of elderly patients 4. This contrasts with its essential role in PAI, where benefits outweigh risks.

Bottom Line Algorithm

Does the patient have primary adrenal insufficiency?

  • YES → Start fludrocortisone 50-100 mcg daily immediately + counsel on salt intake
  • NO (secondary AI) → Fludrocortisone not indicated

Monitor every visit:

  • Orthostatic vital signs
  • Salt craving symptoms
  • Electrolytes (sodium, potassium)
  • Adjust dose based on clinical response and plasma renin activity

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.